1. Home
  2. CXII vs AVTX Comparison

CXII vs AVTX Comparison

Compare CXII & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CXII

Churchill Capital Corp XII Class A Ordinary Shares

N/A

Current Price

$10.49

Market Cap

597.4M

Sector

Finance

ML Signal

N/A

Logo Avalo Therapeutics Inc.

AVTX

Avalo Therapeutics Inc.

HOLD

Current Price

$7.42

Market Cap

710.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXII
AVTX
Founded
2026
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
597.4M
710.1M
IPO Year
2026
2015

Fundamental Metrics

Financial Performance
Metric
CXII
AVTX
Price
$10.49
$7.42
Analyst Decision
Strong Buy
Analyst Count
0
14
Target Price
N/A
★ $34.80
AVG Volume (30 Days)
27.3K
★ 3.0M
Earning Date
N/A
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 72.07
EPS
★ N/A
N/A
Revenue
N/A
★ $27,813,137.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 2312.27
52 Week Low
$10.05
$6.53
52 Week High
$10.99
$24.27

Technical Indicators

Market Signals
Indicator
CXII
AVTX
Relative Strength Index (RSI) 44.45 36.53
Support Level $10.34 $6.53
Resistance Level $10.45 $20.54
Average True Range (ATR) 0.03 0.64
MACD 0.02 0.35
Stochastic Oscillator 41.18 44.51

Price Performance

Historical Comparison
CXII
AVTX

About CXII Churchill Capital Corp XII Class A Ordinary Shares

Churchill Capital Corp XII is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.

Share on Social Networks: